Please login to the form below

Not currently logged in
Email:
Password:

Hong Kong

This page shows the latest Hong Kong news and features for those working in and with pharma, biotech and healthcare.

China’s BeiGene raises $903m from Hong Kong IPO

China’s BeiGene raises $903m from Hong Kong IPO

China’ s BeiGene raises $903m from Hong Kong IPO. Mammoth debut might have exceeded $1bn but for market jitters. ... A Reuters. Hong Kong's Exchange Square: the decision to allow 'pre-revenue' biotechs to list on the HKEX has opened the floodgates.

Latest news

More from news
Approximately 2 fully matching, plus 72 partially matching documents found.

Latest Intelligence

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene is one of a new wave of Chinese biopharma companies to list on the Hong Kong stock exchange, raising a huge $903m when it went public in August. ... However while there are doubts about the robustness of some of the ‘pre-revenue’biotechs now

  • Made in China Made in China

    scale.”. Having just raised a gargantuan $903m via an IPO on the newly deregulated Hong Kong exchange, the company is bullish about becoming one of those Chinese-headquartered global pharma companies, ... In terms of biotech funding, the emergence of

  • Deal Watch February 2017 Deal Watch February 2017

    Greater China (China, Hong Kong, Macao, Taiwan). HIF, hypoxia-inducible factor prolyl hydroxylase.

  • Deal Watch September 2016 Deal Watch September 2016

    SciClone has gained exclusive licensing rights to Soligenix's mid stage oral mucositis candidate SGX942 (dusquetide) in South Korea, Vietnam, Taiwan and China, including Macau and Hong Kong.

  • Harnessing commercial innovation Harnessing commercial innovation

    As SVP of Novo's 'Region China' he took on responsibility for the company's commercial operations in mainland China, Taiwan and Hong Kong.

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics